Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes (CROSBI ID 114010)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Pavelić, Krešimir ; Sirotković, Maja ; Kopitar, Marija ; Pavelić, Jasminka ; Vuk-Pavlović, Stanimir
engleski
Murine myeloid leukemia: in vivo suppression by sericystatin A, a proteinase inhibitor from leukocytes
Parenteral administration of sericystatin A, an intracellular leukocyte inhibitor of the proinsulin-splitting enzyme cathepsin B, prolongs the mean survival time of mice with insulin-dependent myeloid leukemia. Sericystatin A reduces the supranormal blood levels of substances detectable by insulin-specific radioimmunoassay in these animals ; this effect is abolished by concomitant insulin administration. It is concluded that sericystatin A reduces tumor proliferation indirectly, i.e. by reducing circulating insulin levels.
murine myeloid leukemia ; sericistatin A
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
19 (1)
1983.
123-126
objavljeno
0277-5379
10.1016/0277-5379(83)90406-6
Povezanost rada
Temeljne medicinske znanosti